My watch list
my.chemeurope.com  
Login  

Respimat



Respimat, or commonly referred to as Respimat SMI, with the SMI acronym to mean, Soft Mist Inhaler.

Respimat SMI is an advanced drug delivery device in comparison to MDIs or DPIs used for the treatment of Asthma, COPD, and other respiratory conditions.

Its developer, Boehringer Ingelheim, is currently conducting Phase III clinical trials in the US with a variety of their products, such as Spiriva and Combivent.



Sources

Boehinger-Ingelheim information

Respimat Home

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Respimat". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE